The COVID-19 Pandemic: an Appraisal of its Impact on Human Immunodeficiency Virus Infection and Pre-Eclampsia.
Rowen GovenderJagidesa MoodleyThajasvarie NaickerPublished in: Current hypertension reports (2021)
Notably evidence suggests that pregnant women with chronic comorbidities (HIV and pre-eclampsia) may be at a greater risk of contracting or encountering complications from COVID-19. Maternal stress, during a pandemic, as well as home delivery have become potential options for pregnant woman. Nonetheless there is currently a paucity of information on the combined effect of COVID-19 in HIV-associated preeclampsia. Understanding the pathogenesis of COVID-19 could potentially aid in developing effective treatment strategies for COVID-19 in HIV associated preeclampsia. This review article presents a comprehensive analysis of the current data in relation to COVID-19 and its effect on pregnant women, including symptoms, pathogenesis and the possible risk of vertical transmission. This paper also reviews its' interactions and effects on preeclamptic and HIV positive pregnant women with suspected or confirmed COVID-19.
Keyphrases
- coronavirus disease
- hiv positive
- human immunodeficiency virus
- sars cov
- antiretroviral therapy
- pregnant women
- hiv infected
- men who have sex with men
- hepatitis c virus
- hiv testing
- hiv aids
- south africa
- respiratory syndrome coronavirus
- healthcare
- randomized controlled trial
- machine learning
- early onset
- depressive symptoms
- systematic review
- birth weight
- human health
- sleep quality
- gestational age